found a HDAC6 inhibitor, CKD-504, which could dramatically change the tau interactome to degrade pathological tau in amyloid plaques and neurofibrillary tangles of AD model mouse brains through the proteasomal pathway, in the end rescuing cognitive decline in AD model mice (138). The gene discussed is MAPT; the disease is Alzheimer disease.